FDA Orange Book
Generic for Auryxia
Auryxia contains ferric citrate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Auryxia is ferric citrate. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Auryxia and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Auryxia products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | EQ 210MG IRON | Marketed (Rx) | AB | 1 | AB |
NDA 205874, held by KERYX BIOPHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic ferric citrate
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| TEVA PHARMACEUTICALS USA INC | 212563 | AB (A-rated, therapeutically equivalent) | March 11, 2026 | EQ 210MG IRON |
Auryxia patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8093423 | April 21, 2026 | Method of use | U-1577 | 205874 |
| 10300039 | July 21, 2030 | Method of use | U-2549 | 205874 |
| 9387191 | July 21, 2030 | Drug product | None | 205874 |
Auryxia NDC codes
Questions
Is there a generic for Auryxia?
Yes. The generic name for Auryxia is ferric citrate. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Auryxia?
The active ingredient in Auryxia is ferric citrate, per the FDA Orange Book.
When does the Auryxia patent expire?
The last patent listed for Auryxia in the Orange Book expires July 21, 2030. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.